Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Celebrities have access to doctors that most others don’t,” says Jameela Jamil, who flagged the risks of GLP-1s like those ...

A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” second-quarter 2025 ...

Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it ...

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

Tennis star Serena Williams recently attributed her dramatic weight loss to GLP-1 medication but according to “The Good Place ...

GreensKeeper Asset Management, an investment management company, released its second-quarter 2025 investor letter. A copy of ...

Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily ...